Vicarious Surgical (RBOT) Liabilities and Shareholders Equity (2020 - 2025)

Vicarious Surgical (RBOT) reported Liabilities and Shareholders Equity of $19.6 million for Q4 2025, down 71.08% year-over-year from $67.7 million in Q4 2024, and down 33.28% on a QoQ basis from $29.3 million in Q3 2025.

Vicarious Surgical (RBOT) has 6 years of Liabilities and Shareholders Equity data on file, last reported at $19.6 million in Q4 2025.

  • Quarterly Liabilities and Shareholders Equity fell 71.08% year-over-year to $19.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $144.9 million (down 58.25% YoY) and the FY2025 annual result came in at $19.6 million, down 71.08% from the prior year.
  • Liabilities and Shareholders Equity retreated to $19.6 million in Q4 2025 per RBOT's latest filing, from $29.3 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $346.4 million in Q1 2021 and bottomed at $19.6 million in Q4 2025.
  • The 5-year median for Liabilities and Shareholders Equity is $120.5 million (2023), against an average of $133.6 million.
  • The widest annual swing landed in 2021, when Liabilities and Shareholders Equity surged 89224.63%; it then tumbled 71.08% in 2025.
  • Tracing RBOT's Liabilities and Shareholders Equity over 5 years: stood at $181.7 million in 2021, then dropped by 22.78% to $140.3 million in 2022, then decreased by 14.56% to $119.9 million in 2023, then sank by 43.5% to $67.7 million in 2024, then tumbled by 71.08% to $19.6 million in 2025.
  • Per Business Quant, the three latest RBOT Liabilities and Shareholders Equity figures stand at $19.6 million (Q4 2025), $29.3 million (Q3 2025), and $40.9 million (Q2 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 110.43 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 46.29 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 91.49 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 44.35 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 13.32 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 31.92 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 6.63 Bn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 37.13 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 10.74 Bn
10 Vicarious Surgical - - - 19.58 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 19.58 Mn
Sep 30, 2025 29.35 Mn
Jun 30, 2025 40.89 Mn
Mar 31, 2025 55.05 Mn
Dec 31, 2024 67.72 Mn
Sep 30, 2024 80.62 Mn
Jun 30, 2024 93.35 Mn
Mar 31, 2024 105.29 Mn
Dec 31, 2023 119.86 Mn
Sep 30, 2023 132.05 Mn
Jun 30, 2023 104.53 Mn
Mar 31, 2023 121.09 Mn
Dec 31, 2022 140.29 Mn
Sep 30, 2022 150.68 Mn
Jun 30, 2022 164.05 Mn
Mar 31, 2022 179.97 Mn
Dec 31, 2021 181.68 Mn
Sep 30, 2021 193.36 Mn
Jun 30, 2021 345.54 Mn
Mar 31, 2021 346.35 Mn
Dec 31, 2020 17.79 Mn
Sep 30, 2020 346.47 Mn
Jun 30, 2020 386,839.00